Jenoptik Q2 Earnings Call Highlights

4 days ago 19

MarketBeat

Wed, August 12, 2026 astatine 5:02 AM CDT 7 min read

Key Points

Jenoptik (ETR:JEN) reported a instrumentality to gross maturation and a crisp betterment successful profitability successful the archetypal fractional of 2026, supported by request successful its semiconductor-focused operations and beardown bid enactment successful Biophotonics. The institution besides raised the specificity of its full-year outlook, forecasting gross maturation toward the precocious fractional of its erstwhile range.

New Chief Executive Officer Dominic Dorfner, who officially joined the institution connected Aug. 1, said helium had begun visiting Jenoptik sites and gathering employees, customers and different stakeholders. He said photonics offers "a batch of maturation potential" and that his contiguous absorption would beryllium listening and gaining a fuller knowing of the business.

→ SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat

Dorfner besides said Jenoptik is conducting an update of its strategy process. The enforcement committee expects to pass cardinal findings and outcomes "towards the extremity of the twelvemonth astatine the earliest," helium said.

Orders and backlog emergence sharply

Dr. Prisca Havranek-Kosicek said radical bid intake roseate by much than 50% twelvemonth implicit twelvemonth successful the archetypal half, exceeding management's expectations. The summation was led by Semiconductor & Advanced Manufacturing and Biophotonics, lifting the group's book-to-bill ratio to 1.4 and expanding the bid backlog to astir €825 million.

→ 3 Dividend Champion Utilities for a Market That Can't Sit Still

Semiconductor & Advanced Manufacturing benefited from request successful lithography and continued lawsuit enactment successful semiconductor inspection. While second-quarter orders were beneath the first-quarter level, absorption noted that the archetypal 4th had included a ample yearly order.

Read Entire Article